Immuneering-logo (1).png
Immuneering to Participate in the 23rd Annual Needham Virtual Healthcare Conference
03. April 2024 16:05 ET | Immuneering Corporation
Immuneering to Participate in the 23rd Annual Needham Virtual Healthcare Conference
First-Wave-Logo-FINAL-RGB[1].jpg
First Wave BioPharma to Participate In ‘Fireside Chat’ at the 36th Annual Roth Conference
05. März 2024 07:00 ET | First Wave BioPharma, Inc.
BOCA RATON, Fla., March 05, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
First-Wave-Logo-FINAL-RGB[1].jpg
First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024
13. Februar 2024 07:00 ET | First Wave BioPharma, Inc.
BOCA RATON, Fla., Feb. 13, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
First-Wave-Logo-FINAL-RGB[1].jpg
First Wave BioPharma to Participate in BIO Partnering @JPM During “J.P. Morgan Week 2024” 
06. Dezember 2023 07:00 ET | First Wave BioPharma, Inc.
BOCA RATON, Fla., Dec. 06, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc. (NASDAQ: FWBI) (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
First-Wave-Logo-FINAL-RGB[1].jpg
Date and Time Announced for First Wave BioPharma CEO James Sapirstein’s Presentation at the 2023 BIO Investor Forum
10. Oktober 2023 07:00 ET | First Wave BioPharma, Inc.
BOCA RATON, Fla., Oct. 10, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...